Research institute in
Allschwil
30 companies in Research institute based in Allschwil — name and year of registration from the commercial register. The list below shows them all.
All 30 companies in Allschwil
Pharmatrans Sanaq AG
Since 1982 · 11–20 empl.
Pharmatrans Sanaq AG specializes in excipients and active ingredients for the pharmaceutical industry. It supplies products and customized solutions, and provides services including sourcing, packaging, storage and distribution.
Actelion Pharmaceuticals Ltd
Since 1997 · 21–50 empl.
Actelion Pharmaceuticals Ltd is a pharmaceutical company focused on the research, development, and marketing of medicines. The website presents Johnson & Johnson Innovative Medicine’s therapeutic areas, including oncology, immunology, neuroscience, and cardiopulmonary care.
ROLIC Technologies AG
Since 1998 · 11–20 empl.
ROLIC Technologies AG develops and markets ready-to-use formulations and functional films for displays, security documents and other optical-industry applications, as well as thin-film encapsulation materials and barrier films.
Vortex Europe AG
Since 2012 · 1–10 empl.
Vortex Europe AG supplies materials, technologies and equipment for the trenchless rehabilitation of water and sewer infrastructure. Its offerings include pipe and manhole rehabilitation, sewer robotics, cleaning equipment, sensors, technical support and rehabilitation services.
OncoGenomX AG
Since 2019 · 1–10 empl.
OncoGenomX AG develops precision diagnostics and decision support for cancer treatment selection. Its Prediction Star platform analyzes tumor-specific genomic, biological and pathological data alongside clinical patient information to assess treatment options, particularly for breast cancer.
DeltaMem AG
Since 2016 · 11–20 empl.5.0(2)
DeltaMem AG develops membrane-based processes and turnkey plants for solvent recovery and dehydration. Its offerings include pervaporation and vapour permeation, as well as consulting, research, development and service for the pharmaceutical, life sciences, fine chemicals and bioethanol industries.
InCephalo AG
Since 2021 · 1–10 empl.
InCephalo AG develops biologic medicines for diseases of the central nervous system. Its focus is compartment-locked cytokine therapies that act locally, initially for glioblastoma.
BioConcept AG
Since 1988 · 1–10 empl.3.4(7)
BioConcept AG manufactures customized cell culture media and defined media for recombinant protein production. It also supplies life science products and laboratory equipment, including media, reagents, consumables and instruments for cell culture, molecular biology, immunology and microbiology.
Bright Peak Therapeutics AG
Since 2017 · 51–100 empl.5.0(1)
Bright Peak Therapeutics AG is a biotechnology company developing multifunctional precision immunotherapies for cancer. Its work includes multifunctional PD-1 inhibitors that combine novel and validated mechanisms.
DMS Consulting GmbH
Since 2022 · 1–10 empl.
The core activity of VAKUMIN GmbH is the development, manufacture and marketing of high-quality cookware, in particular vacuum cooking pots, which enable energy savings and sustainable kitchen practices through their innovative technology.
Phialogics AG
Since 2022 · 1–10 empl.
INNOSIAMO AG
Since 2024 · 1–10 empl.
INNOSIAMO AG helps startups advance healthcare innovation through collaboration and create and sustain value.
Crystallise! AG
Since 2017 · 1–10 empl.4.0(1)
Crystallise! AG provides crystallization services for active pharmaceutical ingredients and other small molecules, and determines their structures using X-ray and electron diffraction (micro-ED). Its services also include diffraction measurements and data analysis.
Monix Health AG
Since 2025 · 1–10 empl.
Monix Health AG develops biosensor technology for continuous hormone monitoring in women. The company is developing a wearable sensor patch to track hormone data, initially for supporting the timing of IVF treatment.
Nanolynx Biologics AG
Since 2025 · 1–10 empl.
Nanolynx Biologics AG develops conditionally active nanobody-drug conjugates for hard-to-treat solid tumors. Its IntelliBody platform uses generative AI to engineer nanobodies that activate in the acidic tumor environment.
Gubra GmbH
Since 2026 · 1–10 empl.
Gubra GmbH is a biotechnology company operating through Biotech, CRO services and Ventures. It develops peptide-based drug candidates and provides preclinical research and development services across areas such as obesity, liver, kidney, lung and metabolic diseases.
GlioCART GmbH
Since 2025 · 1–10 empl.
GlioCART GmbH develops CAR-T cell therapies for glioblastoma. Its dual-action approach targets tumor cells and the immunosuppressive tumor microenvironment, including through EGFRvIII recognition and reprogramming tumor-associated macrophages.
Swiss Biome Institute GmbH
Since 2025 · 1–10 empl.
Swiss Biome Institute GmbH provides microbiome analysis to support clinical trials in functional foods, biotherapeutics and microbiota research. The institute performs advanced omics analyses (genomics, transcriptomics, proteomics, metabolomics), supports product efficacy validation and R&D project planning and implementation including computational analysis, and conducts epigenetic and mitochondrial research related to longevity using AI and in vivo studies.
Cancentus GmbH
Since 2026 · 1–10 empl.
Cancentus GmbH develops cancer therapies that target DNA replication stress in cancer cells. Its programs include novel payloads for antibody-drug conjugates, a helicase inhibitor and drug combinations; the company also offers AI-driven compound screening and lead optimization.
Immuna Therapeutics AG
Since 2025 · 1–10 empl.
Immuna Therapeutics AG develops cell and gene therapies, with a focus on CAR-T and gene therapy platforms for blood cancers and other indications. The company supports hospitals and health systems with decentralized GMP manufacturing, regulatory support, and commercialization.
BIIE AI Initiative AG
Since 2025 · 1–10 empl.
BIIE AI Initiative AG is the AI initiative of the Botnar Institute of Immune Engineering (BIIE). The website mainly provides privacy policy information and a contact/newsletter form; it contains little detail about specific products or services.
SRS Schärer Research Services
Since 2002 · 1–10 empl.
Intelligence Research Services GmbH
Since 2003 · 1–10 empl.
Auxenion Research AG
Since 2017 · 1–10 empl.
noul GmbH
Since 2019 · 1–10 empl.
Treeline Biosciences GmbH
Since 2023 · 1–10 empl.
EqVita AG
Since 2024 · 1–10 empl.
Sironax Switzerland GmbH
Since 2025 · 1–10 empl.
NexGen Therapeutics GmbH
Since 2025 · 1–10 empl.
Zhang Auberson Clinical Development Consulting
Since 2026 · 1–10 empl.
Research institute in Allschwil
Research institute in the region
Point size by number of companies per place.
Source: commercial register (Zefix) · as of November 7, 2026
Research institute in other places
By canton